State Street SPDR S&P Pharmaceuticals ETF
Not enough financial coverage to compute a composite score for XPH. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.ssga.com/us/en/intermediary/etfs/funds/spdr-sp-pharmaceuticals-etf-xph?fundSeoName=spdr-sp-pharmaceuticals-etf-XPH
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
- IPO
- 2006
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $230.88M
- Div Yield
- 0.65%
Performance & Tape
- 52W High
- $60.73
- 52W Low
- $39.21
- 50D MA
- $56.20
- 200D MA
- $52.89
- Beta
- 0.85
- Avg Volume
- 57.54K
Get TickerSpark's AI analysis on XPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our XPH Coverage
We haven't published any research on XPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XPH Report →